If you're interested in becoming a contributor or requesting changes then click here to join the discord
Difference between revisions of "NeuroSigma"
Landonodnal (talk | contribs) |
Landonodnal (talk | contribs) |
||
| Line 1: | Line 1: | ||
| + | [[Category:Twitter Accounts]] | ||
[[Category:Organizations]] | [[Category:Organizations]] | ||
[[Category:Companies]] | [[Category:Companies]] | ||
| Line 15: | Line 16: | ||
[https://www.neurosigma.com/ Website] | [https://www.neurosigma.com/ Website] | ||
[https://www.crunchbase.com/organization/neurosigma Crunchbase] | [https://www.crunchbase.com/organization/neurosigma Crunchbase] | ||
| + | [https://twitter.com/Neurosigma Twitter] | ||
Revision as of 22:37, 20 April 2022
NeuroSigma is a California-based life sciences company established to develop bioelectronic technologies with the potential to transform medical practice and patients' lives. NeuroSigma is focused on TNS neuromodulation therapies based on intellectual property, licensed on an exclusive basis from the University of California, Los Angeles (UCLA), covering a wide-spectrum of disorders, including ADHD.
Founded in The United States around 2008, NeuroSigma produces noninvasive hardware.
NeuroSigma makes tools for medical diagnosis and treatment through body/mind state interpretation and/or neurostimulation therapies.
BCI Categories: Open-Loop Afferent
Neurostimulation Technique(s): TNS